A Panel of Three Biomarkers Identified by iTRAQ for the Early Diagnosis of Pancreatic Cancer.

Xing WuZi-Xiang ZhangXing-Yu ChenYa-Ling XuNi YinJian YangDong-Ming ZhuDe-Chun LiJian Zhou

Published in: Proteomics. Clinical applications (2019)

It is demonstrated that PROZ and TNFRSF6B are novel serum biomarkers for detecting early stage PC, and for distinguishing PC from pancreatic benign tumor and healthy individuals. Additional large cohort studies are needed to develop PROZ and TNFRSF6B as clinical PC biomarkers.

Keyphrases

early stage
squamous cell carcinoma
radiation therapy
lymph node
neoadjuvant chemotherapy
rectal cancer